申请人:AGIOS PHARMACEUTICALS, INC
公开号:US20170007608A1
公开(公告)日:2017-01-12
The invention described herein features methods, compositions, and kits that utilize activators of pyruvate kinase M2 (PKM2) for the treatment or amelioration of disorders related to PKM2 function and characterized by abnormally low levels of serine.